Life Technologies Buys Certain Assets of Indian Firm Labindia | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced a definitive agreement to buy certain assets from Indian firm Labindia for an undisclosed amount.

Labindia has been a distributor of Life Tech's Applied Biosystems products, including the SOLiD sequencing system and Ambion RNA reagents, since 1994. The deal creates a full service business, allowing Life Tech to supply ABI and Invitrogen products directly to customers, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.